佳礼资讯网

 找回密码
 注册

ADVERTISEMENT

楼主: icy97

【KANGER 0170 交流专区】康尔国际

  [复制链接]
 楼主| 发表于 11-10-2020 08:51 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2020
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Mar 2020
31 Mar 2019
31 Mar 2020
31 Mar 2019
$$'000
$$'000
$$'000
$$'000
1Revenue
11,257
18,040
11,257
18,040
2Profit/(loss) before tax
-4,373
1,399
-4,373
1,399
3Profit/(loss) for the period
-4,385
1,370
-4,385
1,370
4Profit/(loss) attributable to ordinary equity holders of the parent
-4,293
1,370
-4,293
1,370
5Basic earnings/(loss) per share (Subunit)
-0.35
0.15
-0.35
0.15
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.1277
0.1526

回复

使用道具 举报


ADVERTISEMENT

发表于 13-10-2020 04:56 PM | 显示全部楼层
回复

使用道具 举报

 楼主| 发表于 14-10-2020 08:30 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
Kanger International Berhad ("Kanger" or "Company") and its subsidiary companies ("Group")- Joint Venture Collaboration Agreement between the Group and Stoika Sdn. Bhd.- Agreement to act as Subdistributor between the Group and Stoika Sdn. Bhd.- Media Release - Kanger Collaborates with Stoika to distribute long-lasting Antimicrobial Coating Solutions
The Board of Directors of Kanger is pleased to announce that the Group has entered into a Joint Venture Collaboration Agreement and Subdistributor Appointment Agreement with Stoika Sdn. Bhd.

Please refer to the full announcements and Media Release as attached.

This announcement is dated 1 July 2020.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3065274

回复

使用道具 举报

 楼主| 发表于 24-10-2020 10:14 AM | 显示全部楼层
KANGER INTERNATIONAL BERHAD

Type
Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID
IQL-03072020-00001
Subject
Joint Venture Collaboration Agreement Between Kanger International Berhad and Stoika Sdn. Bhd. ("JV")
Description
Kanger International Berhad ("Kanger" or "Company") and its subsidiary companies ("Group")- Joint Venture Collaboration Agreement between the Group and Stoika Sdn. Bhd.- Agreement to act as Subdistributor between the Group and Stoika Sdn. Bhd.- Media Release - Kanger Collaborates with Stoika to distribute long-lasting Antimicrobial Coating Solutions
Query Letter Contents
We refer to your Company’s announcement dated 1 July 2020, in respect of the aforesaid matter.

In this connection, kindly furnish Bursa Securities with the following additional information for public release:-
  • The name of the joint-venture corporation (“JVC”).
  • The eventual share capital and number of issued shares of the JVC.
  • The source(s) of funds for financing the investment in the JVC  and the breakdown.
  • The targeted countries in which the products will be distributed, marketed and sold.
  • Expected date of commencement of the JVC’s operations.
  • The relevant regulatory approvals required to be obtained for the distribution, marketing and sale of the anti-microbial coating solutions.
  • Business risk or exposure in relation to the JV.
  • Prospects of the JV.
We refer to the Company’s announcement dated 1 July 2020 and the queries from Bursa Malaysia Securities Berhad dated 3 July 2020 (“Queries”) in relation to the same.

The Company wishes to provide the following additional information pursuant to the Queries.

Please refer to the attachment for the details.

This announcement is dated 6 July 2020.
Attachments

回复

使用道具 举报

 楼主| 发表于 23-11-2020 09:24 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
Kanger International Berhad ("Kanger" or "Company") and its subsidiary companies ("Group")- Joint Venture Collaboration Agreement between the Group and Stoika Sdn. Bhd.- Agreement to act as Subdistributor between the Group and Stoika Sdn. Bhd.
We refer to our announcements dated 1 July 2020 and 6 July 2020 in relation to the Joint Venture Collaboration Agreement between Kanger and Stoika Sdn. Bhd. Unless otherwise stated, the defined terms used in this announcement shall carry the same meaning as defined in the earlier announcements made.

The Board of Directors of Kanger wishes to announce that the Company had incorporated the Joint Venture Company namely, Viridis Global Sdn Bhd (“VGSB”) in Malaysia under the Companies Act 2016 on 3 August 2020.

The issued and paid-up share capital of VGSB is RM100.00 comprising 100 ordinary shares currently and it will be further increased to RM100,000.00 comprising 100,000 ordinary shares in due course. The principal activity of VGSB is the marketing and distribution of long lasting antimicrobial coating solutions. The Directors of VGSB are Mr Wu Wai Kong, Encik Syed Hazrain bin Syed Razlan Jamalullail, Dr Tan Kim Leong and Dr Lau Haw Ming.

Save as disclosed above, none of the Directors, substantial shareholders and persons connected with the Directors or substantial shareholders of Kanger has any interest, direct or indirect, in the incorporation of VGSB.

The incorporation is not expected to have any material effects on the earnings, earnings per share and net assets of the Company for the financial year ending 31 December 2020, beyond any income earned from new sales or contracts carried out during the year.

This announcement is dated 3 August 2020.



回复

使用道具 举报

 楼主| 发表于 8-12-2020 07:17 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
Kanger International Berhad ("Kanger" or "Company") and its subsidiary companies ("Group")- Expression of Interest Letter from Constellation Holdings Limited
Kanger would like to announce that is has received a formal Expression of Interest letter (“EOI”) dated 9 August 2020 from Constellation Holdings Limited, Dubai (“Constellation”) for collaboration in the setting up of medical examination gloves operations in Malaysia.

Constellation is the appointed procurement agent for personal protective equipment, medical equipment and supplies for the Ministry of Health & Prevention of the United Arab Emirates, as well as other countries in the Middle Eastern region.

The EOI expresses Constellation’s willingness to collaborate with Kanger through several options, which include direct equity participation in the formation of a joint-venture entity and/or indirect equity holding in the glove manufacturing operations via investment into Kanger through a private placement exercise, wherein Constellation will seek to become a substantial shareholder of Kanger.

The Board is considering the proposals set forth in the EOI and will continue to engage with Constellation to achieve an outcome that is in the best interest of the Company and all stakeholders.

This announcement is dated 11 August 2020.



回复

使用道具 举报

Follow Us
 楼主| 发表于 12-12-2020 08:37 AM | 显示全部楼层
Type
Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID
IQL-12082020-00001
Subject
Expression on Interest Letter from Constellation Holdings Limited (Constellation) for collaboration on the setting up of medical examination gloves manufacturing operation in Malaysia (EOI)
Description
Kanger International Berhad ("Kanger" or "Company") and its subsidiary companies ("Group")- Expression of Interest Letter from Constellation Holdings Limited
Query Letter Contents
We refer to your Company’s announcement dated 11 August 2020, in respect of the aforesaid matter.

In this connection, kindly furnish Bursa Securities with the following additional information for public release:-
  • Whether Kanger International Berhad (“Kanger”) possesses the requisite experience/expertise to manufacture the medical gloves. If no, how Kanger intends to acquire this experience/expertise.
  • The relevant regulatory approvals required to be obtained before Kanger can commence  the medical examination gloves manufacturing operation.
  • The date Kanger received the EOI.
  • Duration of the EOI (commencement and expiry dates).
  • The party which appointed Constellation as procurement agent for personal protective equipment, medical equipment and supplies for the Ministry of Health & Prevention of the United Arab Emirates, as well as other countries in the Middle Eastern region.
  • To name the other countries in Middle Eastern region for which Constellation is the appointed procurement agent for personal protective equipment, medical equipment and supplies.
  • Whether any details of the medical examination gloves factory(ies) have been decided. If so, the relevant details pertaining thereto.
  • A statement that an immediate announcement will be made once the relevant definitive agreement(s) has/have been entered into, and as and when there are any material development.
  • The markets for the medical examination gloves to be manufactured.
  • The expected effects of the medical examination gloves manufacturing operation business on the earnings/profitability of Kanger group.
  • The prospects of the medical examination gloves manufacturing operation business.
  • The business risks of the medical examination gloves manufacturing operation business.
We refer to the Company’s announcement dated 11 August 2020 and the queries from Bursa Malaysia Securities Berhad dated 12 August 2020 (“Queries”) in relation to the same.

The Company wishes to provide the following additional information pursuant to the Queries.

Please refer to the attachment for the details.

This announcement is dated 13 August 2020.
Attachments

回复

使用道具 举报

 楼主| 发表于 13-12-2020 08:20 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
Kanger International Berhad ("Kanger" or "Company") and its subsidiary companies ("Group")- Execution of Heads of Agreement
The Board of Directors of Kanger wishes to announce that the Company had, on 13 August 2020 entered into a heads of agreement with Constellation Holdings Limited.

Please refer to the full announcement as attached.

This announcement is dated 14 August 2020.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3077850

回复

使用道具 举报


ADVERTISEMENT

 楼主| 发表于 16-12-2020 04:45 AM | 显示全部楼层
KANGER INTERNATIONAL BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
Others
Details of corporate proposal
Conversion of Redeemable Convertible Notes
No. of shares issued under this corporate proposal
458,333,333
Issue price per share ($$)
Malaysian Ringgit (MYR)   0.0720
Par Value($$) (if applicable)
Malaysian Ringgit (MYR)   0.000
Latest issued share capital after the above corporate proposal in the following
Units
1,693,587,988
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 147,226,459.930
Listing Date
21 Aug 2020

回复

使用道具 举报

 楼主| 发表于 16-12-2020 08:01 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2020
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Jun 2020
30 Jun 2019
30 Jun 2020
30 Jun 2019
$$'000
$$'000
$$'000
$$'000
1Revenue
12,219
21,710
23,476
39,750
2Profit/(loss) before tax
-50
3,131
-4,423
4,530
3Profit/(loss) for the period
-38
3,256
-4,423
4,626
4Profit/(loss) attributable to ordinary equity holders of the parent
208
3,264
-4,085
4,634
5Basic earnings/(loss) per share (Subunit)
0.02
0.36
-0.33
0.52
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.1293
0.1526

回复

使用道具 举报

 楼主| 发表于 19-12-2020 07:28 AM | 显示全部楼层
Type
Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID
IQL-18082020-00004
Subject
Execution of Heads of Agreement with Constellation Holdings Limited (Constellation)
Description
Kanger International Berhad ("Kanger" or "Company") and its subsidiary companies ("Group")- Execution of Heads of Agreement
Query Letter Contents
We refer to your Company’s announcement dated 14 August 2020, in respect of the aforesaid matter.

In this connection, kindly furnish Bursa Securities with the following additional information for public release:-

1) The number of  issued shares of Kanger Glove Manufacturing Sdn Bhd (“Kanger Glove”).
2) The purchase consideration of the Land and the basis thereof.
3) The name of the vendor of the Land including the names of its directors and substantial   
    shareholders together with their respective direct and/or indirect shareholdings, and date and   
    place of incorporation, if the vendor is a corporation.
4) Information on the Land as per Item (1), Appendix10A, Part C of the Listing Requirements.
5) The basis of the estimated value of the Land of approximately RM6,800,000.
6) The sources of funds to Kanger Glove to build the factory and install the 8 production lines, and  
    the breakdown thereof.
7) The expected production capacity and output of the factory.
8) The expected commencement and completion date(s) of development of the factory.
9) The risks in relation to the Business.
10)The prospect of the Business.
11)Whether the acquisition of the Land is subject to shareholders’ approval.
12)Whether the building and setting-up of the factory  requires any government approvals. If so, the estimated time frame for submission and approvals to be obtained.
We refer to the Company’s announcement dated 14 August 2020 and the queries from Bursa Malaysia Securities Berhad dated 19 August 2020 (“Queries”) in relation to the same.

The Company wishes to provide the following additional information pursuant to the Queries.

Please refer to the attachment for the details.

This announcement is dated 21 August 2020.
Attachments

回复

使用道具 举报

 楼主| 发表于 20-12-2020 09:17 AM | 显示全部楼层
KANGER INTERNATIONAL BERHAD

Date of change
24 Aug 2020
Name
MR KUAH CHOON CHING
Age
35
Gender
Male
Nationality
Malaysia
Designation
Director
Directorate
Executive
Type of change
Appointment
Qualifications
No
Qualifications
Major/Field of Study
Institute/University
Additional Information
1
Degree
Mechanical Engineering
University of Sunderland, United Kingdom

Working experience and occupation
Mr Kuah is an experienced businessman and entrepreneur with a proven track record in the diverse sectors of consumer products, property development, and manufacturing for various packaging industries.  Mr Kuah started his career in the United Kingdom upon graduating from the University of Sunderland. He worked in the a Group of Companies, which was involved in trading and distributing products within the downstream of Oil and Gas Industry. He resigned and founded CCK Petroleum Group in 2007, and is the Group Managing Director of CCK Group today. Under his leadership, the Group has seen significant growth and has expanded its operations to cover international marine oil bunkering, oil tanker carrier operation, marine lubricants and marine oil trading.  Due to his diverse experience, he was later appointed as an Executive Director of Dnonce Technology Berhad on 2 May 2018, and was subsequently promoted to Chief Executive Officer on 1 September 2018.  During his tenure in Dnonce Technology Berhad, he spearheaded corporate exercises such as fund raising, diversification and share buy-back exercises for the company.  As the CEO, he played an active role in streamlining the diverse operations of the Group through an agile, focus-based strategy. Mr. Kuah is very well versed in various industries, such as manufacturing and printing for the glove making, medical, electrical and electronics, automotive industries and more.

回复

使用道具 举报

 楼主| 发表于 20-12-2020 09:20 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
Kanger International Berhad ("Kanger" or "Company") and its subsidiary companies ("Group")- Proposed Acquisition of Properties by the Company
The Board of Directors of Kanger wishes to announce that the Company has on 24 August 2020 entered into Sales and Purchase Agreements with Poh Lin Estate Sdn. Bhd. for the proposed acquisition of three (3) units vacant leasehold agriculture land for the purchase price of RM6,800,000.00.

Please refer to the attachment for the details.

This announcement is dated 24 August 2020.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3080552

回复

使用道具 举报

 楼主| 发表于 26-12-2020 07:34 AM | 显示全部楼层
KANGER INTERNATIONAL BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
Others
Details of corporate proposal
Share Issuance Scheme
No. of shares issued under this corporate proposal
28,000,000
Issue price per share ($$)
Malaysian Ringgit (MYR)   0.0650
Par Value($$) (if applicable)
Malaysian Ringgit (MYR)   0.000
Latest issued share capital after the above corporate proposal in the following
Units
1,721,587,988
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 149,046,459.930
Listing Date
27 Aug 2020

回复

使用道具 举报

 楼主| 发表于 6-1-2021 07:22 AM | 显示全部楼层
KANGER INTERNATIONAL BERHAD

Information Compiled By KLSE
Particulars of Director
Name
MR KENNETH HOOI CHI-KIN @ ZARIF KENNETH HOOI
Descriptions(Class)
Ordinary Shares
Details of changes
No
Date of change
No of securities
Type of transaction
Nature of Interest
1
25/08/2020
28,000,000
Acquired
Direct Interest
Name of registered holder
Kenanga Nominees (Tempatan) Sdn Bhd for Kenneth Hooi Chi-Kin
Description of "Others" Type of Transaction
Consideration (if any)
RM0.065
2
26/08/2020
12,000,000
Acquired
Direct Interest
Name of registered holder
Kenanga Nominees (Tempatan) Sdn Bhd for Kenneth Hooi Chi-Kin
Description of "Others" Type of Transaction
Consideration (if any)
RM0.065

Circumstances by reason of which change has occurred
Exercise of Share Issuance Scheme
Nature of interest
Direct Interest
Total no of securities after change
Direct (units)
40,000,000
Direct (%)
2.307
Indirect/deemed interest (units)
0
Indirect/deemed interest (%)
0.000
Date of notice
28/08/2020
Date notice received by Listed Issuer
28/08/2020

回复

使用道具 举报

 楼主| 发表于 6-1-2021 07:24 AM | 显示全部楼层
KANGER INTERNATIONAL BERHAD

Date of change
28 Aug 2020
Name
ENCIK SYED HAZRAIN BIN SYED RAZLAN JAMALULLAIL
Age
42
Gender
Male
Nationality
Malaysia
Designation
Executive Director
Directorate
Executive
Type of change
Resignation
Reason
Due to his other personal commitments.




Date of change
28 Aug 2020
Name
DATO' KUAN AH HOCK
Age
56
Gender
Male
Nationality
Malaysia
Designation
Deputy Chairman
Directorate
Non Independent and Non Executive
Type of change
Resignation
Reason
Due to his other personal commitments.




Date of change
28 Aug 2020
Name
MR KENNETH HOOI CHI-KIN @ ZARIF KENNETH HOOI
Age
47
Gender
Male
Nationality
Malaysia
Designation
Executive Director
Directorate
Executive
Type of change
Resignation
Reason
Due to his other personal commitments.

回复

使用道具 举报


ADVERTISEMENT

 楼主| 发表于 8-1-2021 07:19 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
Kanger International Berhad ("Kanger" or "Company") and its subsidiary companies ("Group")- Incorporation of Kanger Technology Sdn. Bhd.
The Board of Directors of Kanger wishes to announce that the Company had incorporated a new wholly-owned subsidiary namely, Kanger Technology Sdn. Bhd. (“KTSB”) in Malaysia under the Companies Act 2016 on 1 September 2020.

The issued and paid-up share capital of KTSB are RM2.00 comprising 2 ordinary shares. The principal activity of KTSB is to provide software development, e-payment, artificial intelligence and information technology services. The Directors of KTSB are Mr Wu Wai Kong and Mr Kuah Choon Ching.

Save as disclosed above, none of the Directors, major shareholders, Chief Executive of the Company and persons connected with them has any interest, direct or indirect, in the incorporation of KTSB.

The incorporation is not expected to have any material effects on the earnings, earnings per share and net assets of the Company for the financial year ending 31 December 2020.

This announcement is dated 2 September 2020.



回复

使用道具 举报

 楼主| 发表于 16-1-2021 07:17 AM | 显示全部楼层
KANGER INTERNATIONAL BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
Others
Details of corporate proposal
Conversion of Redeemable Convertible Notes
No. of shares issued under this corporate proposal
98,765,432
Issue price per share ($$)
Malaysian Ringgit (MYR)   0.0810
Par Value($$) (if applicable)
Malaysian Ringgit (MYR)   0.000
Latest issued share capital after the above corporate proposal in the following
Units
1,832,353,420
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 155,226,459.922
Listing Date
18 Sep 2020

回复

使用道具 举报

 楼主| 发表于 19-1-2021 08:45 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
Kanger International Berhad ("Kanger" or "Company") and its subsidiary companies ("Group")- Proxy Agreement with Shenzhen Public Health Technology Co., Ltd.
The Board of Directors of Kanger is pleased to announce that the Company has entered into a Proxy Agreement with Shenzhen Public Health Technology Co., Ltd.

Please refer to the full announcement as attached.

This announcement is dated 22 September 2020.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3090087
回复

使用道具 举报

 楼主| 发表于 23-1-2021 10:19 AM | 显示全部楼层
Type
Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID
IQL-23092020-00004
Subject
Proxy agreement with Shenzhen Public Health Technology Co., Ltd (SZPHT) (Agreement)
Description
Kanger International Berhad ("Kanger" or "Company") and its subsidiary companies ("Group")- Proxy Agreement with Shenzhen Public Health Technology Co., Ltd.
Query Letter Contents
We refer to your Company’s announcement dated 22 September 2020, in respect of the aforesaid matter.

In this connection, kindly furnish Bursa Securities with the following additional information for public release:-
  • The principal activities of SZPHT.
  • The relevant regulatory approvals required to be obtained before Kanger can commence  the dealership/distributorship of the potential Covid-19 Vaccines to the relevant countries.
  • A statement that an immediate announcement will be made once the relevant dealership/distributorship agreement(s) has/have been entered into, and as and when there are any material development.
  • The costs and/or sum due to SZPHT under the Agreement, in the event SZPHT fails to secure the dealership / distributorship from CNBG/SINOPHARM for the potential COVID-19 Vaccines (Vero Cell).
  • The risks of the distribution of COVID-19 Vaccines.
We refer to the Company’s announcement dated 22 September 2020 and the queries from Bursa Malaysia Securities Berhad dated 23 September 2020 (“Queries”) in relation to the same.

The Company wishes to provide the following additional information pursuant to the Queries.

Please refer to the attachment for the details.

This announcement is dated 24 September 2020.
Attachments

回复

使用道具 举报

您需要登录后才可以回帖 登录 | 注册

本版积分规则

 

ADVERTISEMENT



ADVERTISEMENT



ADVERTISEMENT

ADVERTISEMENT


版权所有 © 1996-2023 Cari Internet Sdn Bhd (483575-W)|IPSERVERONE 提供云主机|广告刊登|关于我们|私隐权|免控|投诉|联络|脸书|佳礼资讯网

GMT+8, 31-1-2025 09:43 AM , Processed in 0.121511 second(s), 20 queries , Gzip On.

Powered by Discuz! X3.4

Copyright © 2001-2021, Tencent Cloud.

快速回复 返回顶部 返回列表